Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 509

1.

Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo.

Pearlstein TB, Halbreich U, Batzar ED, Brown CS, Endicott J, Frank E, Freeman EW, Harrison WM, Haskett RF, Stout AL, Yonkers KA.

J Clin Psychiatry. 2000 Feb;61(2):101-9.

PMID:
10732657
2.

Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment.

Rapaport MH, Endicott J, Clary CM.

J Clin Psychiatry. 2002 Jan;63(1):59-65.

PMID:
11838628
3.
4.

Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome.

Halbreich U, Smoller JW.

J Clin Psychiatry. 1997 Sep;58(9):399-402.

PMID:
9378691
5.

Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder.

Halbreich U, Bergeron R, Yonkers KA, Freeman E, Stout AL, Cohen L.

Obstet Gynecol. 2002 Dec;100(6):1219-29.

PMID:
12468166
6.

Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies.

Kornstein SG, Pearlstein TB, Fayyad R, Farfel GM, Gillespie JA.

J Clin Psychiatry. 2006 Oct;67(10):1624-32.

PMID:
17107257
7.

Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study.

Jermain DM, Preece CK, Sykes RL, Kuehl TJ, Sulak PJ.

Arch Fam Med. 1999 Jul-Aug;8(4):328-32.

PMID:
10418540
8.

Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial.

Freeman EW, Rickels K, Sondheimer SJ, Polansky M.

Arch Gen Psychiatry. 1999 Oct;56(10):932-9.

PMID:
10530636
9.

Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase.

Yonkers KA, Pearlstein T, Fayyad R, Gillespie JA.

J Affect Disord. 2005 Apr;85(3):317-21.

PMID:
15780701
10.

[Psychiatric and psychological aspects of premenstrual syndrome].

Limosin F, Ades J.

Encephale. 2001 Nov-Dec;27(6):501-8. Review. French.

PMID:
11865558
11.

Pretreatment pattern of symptom expression in premenstrual dysphoric disorder.

Pearlstein T, Yonkers KA, Fayyad R, Gillespie JA.

J Affect Disord. 2005 Apr;85(3):275-82.

PMID:
15780697
12.

Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.

Ravindran AV, Guelfi JD, Lane RM, Cassano GB.

J Clin Psychiatry. 2000 Nov;61(11):821-7.

PMID:
11105734
13.
14.

Predictors of response to sertraline treatment of severe premenstrual syndromes.

Freeman EW, Sondheimer SJ, Polansky M, Garcia-Espagna B.

J Clin Psychiatry. 2000 Aug;61(8):579-84.

PMID:
10982201
15.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
16.

A preliminary study of luteal phase versus symptom-onset dosing with escitalopram for premenstrual dysphoric disorder.

Freeman EW, Sondheimer SJ, Sammel MD, Ferdousi T, Lin H.

J Clin Psychiatry. 2005 Jun;66(6):769-73.

PMID:
15960573
17.

Sertraline versus desipramine in the treatment of premenstrual syndrome: an open-label trial.

Freeman EW, Rickels K, Sondheimer SJ, Wittmaack FM.

J Clin Psychiatry. 1996 Jan;57(1):7-11.

PMID:
8543554
18.

A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.

Lydiard RB, Stahl SM, Hertzman M, Harrison WM.

J Clin Psychiatry. 1997 Nov;58(11):484-91.

PMID:
9413414
19.

Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group.

Yonkers KA, Halbreich U, Freeman E, Brown C, Endicott J, Frank E, Parry B, Pearlstein T, Severino S, Stout A, Stone A, Harrison W.

JAMA. 1997 Sep 24;278(12):983-8.

PMID:
9307345
20.

Paroxetine controlled release for premenstrual dysphoric disorder: a double-blind, placebo-controlled trial.

Cohen LS, Soares CN, Yonkers KA, Bellew KM, Bridges IM, Steiner M.

Psychosom Med. 2004 Sep-Oct;66(5):707-13.

PMID:
15385695

Supplemental Content

Support Center